Follow the people · Insider
Nikita Shah
Nikita Shah files insider transactions with the SEC as an executive vice president of Amneal Pharmaceuticals (AMRX). We hold 1 disclosed purchase or sale filed since 9 May 2018, 1 of them in the last 90 days.
- Files forAMRX
- Disclosed buys and sells1 in all, 1 in the last 90 days
- Last disclosure13 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 7 May 2018 — 12 August 2026Executive Vice President · Amneal Pharmaceuticals (AMRX)141 Form 4 lines · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 146,403 shares of Amneal PharmaceuticalsSEC Form 413 August 2026Class A Common Stock · traded 12 August 2026 · filed 13 August 2026
- exercised options over 36,232 shares of Amneal PharmaceuticalsSEC Form 45 March 2026Class A Common Stock · traded 3 March 2026 · filed 5 March 2026
- had shares withheld for tax on 17,976 shares of Amneal PharmaceuticalsSEC Form 45 March 2026Class A Common Stock · traded 4 March 2026 · filed 5 March 2026
- exercised options over 36,232 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 45 March 2026Restricted Stock Units · traded 3 March 2026 · filed 5 March 2026
- exercised options over 45,871 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 45 March 2026Restricted Stock Units · traded 3 March 2026 · filed 5 March 2026
- exercised options over 23,544 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 45 March 2026Restricted Stock Units · traded 3 March 2026 · filed 5 March 2026
- exercised options over 366,972 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 45 March 2026Performance-Based Restricted Stock Units · traded 3 March 2026 · filed 5 March 2026
- exercised options over 35,880 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 45 March 2026Restricted Stock Units · traded 4 March 2026 · filed 5 March 2026
- had shares withheld for tax on 18,502 shares of Amneal PharmaceuticalsSEC Form 45 March 2026Class A Common Stock · traded 3 March 2026 · filed 5 March 2026
- exercised options over 45,871 shares of Amneal PharmaceuticalsSEC Form 45 March 2026Class A Common Stock · traded 3 March 2026 · filed 5 March 2026
- exercised options over 36,232 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 45 March 2026Restricted Stock Units · traded 3 March 2026 · filed 5 March 2026
- exercised options over 45,871 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 45 March 2026Restricted Stock Units · traded 3 March 2026 · filed 5 March 2026
- exercised options over 23,544 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 45 March 2026Restricted Stock Units · traded 3 March 2026 · filed 5 March 2026
- exercised options over 366,972 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 45 March 2026Performance-Based Restricted Stock Units · traded 3 March 2026 · filed 5 March 2026
- exercised options over 35,880 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 45 March 2026Restricted Stock Units · traded 4 March 2026 · filed 5 March 2026
- had shares withheld for tax on 22,982 shares of Amneal PharmaceuticalsSEC Form 45 March 2026Class A Common Stock · traded 3 March 2026 · filed 5 March 2026
- exercised options over 23,544 shares of Amneal PharmaceuticalsSEC Form 45 March 2026Class A Common Stock · traded 3 March 2026 · filed 5 March 2026
- had shares withheld for tax on 11,796 shares of Amneal PharmaceuticalsSEC Form 45 March 2026Class A Common Stock · traded 3 March 2026 · filed 5 March 2026
- exercised options over 366,972 shares of Amneal PharmaceuticalsSEC Form 45 March 2026Class A Common Stock · traded 3 March 2026 · filed 5 March 2026
- had shares withheld for tax on 183,853 shares of Amneal PharmaceuticalsSEC Form 45 March 2026Class A Common Stock · traded 3 March 2026 · filed 5 March 2026
- exercised options over 36,232 shares of Amneal PharmaceuticalsSEC Form 45 March 2026Class A Common Stock · traded 3 March 2026 · filed 5 March 2026
- had shares withheld for tax on 18,502 shares of Amneal PharmaceuticalsSEC Form 45 March 2026Class A Common Stock · traded 3 March 2026 · filed 5 March 2026
- exercised options over 45,871 shares of Amneal PharmaceuticalsSEC Form 45 March 2026Class A Common Stock · traded 3 March 2026 · filed 5 March 2026
- had shares withheld for tax on 22,982 shares of Amneal PharmaceuticalsSEC Form 45 March 2026Class A Common Stock · traded 3 March 2026 · filed 5 March 2026
- exercised options over 23,544 shares of Amneal PharmaceuticalsSEC Form 45 March 2026Class A Common Stock · traded 3 March 2026 · filed 5 March 2026
- had shares withheld for tax on 11,796 shares of Amneal PharmaceuticalsSEC Form 45 March 2026Class A Common Stock · traded 3 March 2026 · filed 5 March 2026
- exercised options over 366,972 shares of Amneal PharmaceuticalsSEC Form 45 March 2026Class A Common Stock · traded 3 March 2026 · filed 5 March 2026
- had shares withheld for tax on 183,853 shares of Amneal PharmaceuticalsSEC Form 45 March 2026Class A Common Stock · traded 3 March 2026 · filed 5 March 2026
- exercised options over 35,880 shares of Amneal PharmaceuticalsSEC Form 45 March 2026Class A Common Stock · traded 4 March 2026 · filed 5 March 2026
- had shares withheld for tax on 17,976 shares of Amneal PharmaceuticalsSEC Form 45 March 2026Class A Common Stock · traded 4 March 2026 · filed 5 March 2026
- exercised options over 35,880 shares of Amneal PharmaceuticalsSEC Form 45 March 2026Class A Common Stock · traded 4 March 2026 · filed 5 March 2026
- was granted 65,359 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 43 March 2026Restricted Stock Units · traded 2 March 2026 · filed 3 March 2026
- was granted 65,359 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 43 March 2026Performance-Based Restricted Stock Units · traded 2 March 2026 · filed 3 March 2026
- was granted 65,359 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 43 March 2026Restricted Stock Units · traded 2 March 2026 · filed 3 March 2026
- was granted 65,359 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 43 March 2026Performance-Based Restricted Stock Units · traded 2 March 2026 · filed 3 March 2026
- exercised options over 36,331 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 414 November 2025Stock Option (Right to Buy) · traded 12 November 2025 · filed 14 November 2025
- exercised options over 95,525 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 414 November 2025Stock Option (Right to Buy) · traded 12 November 2025 · filed 14 November 2025
- exercised options over 36,331 shares of Amneal PharmaceuticalsSEC Form 414 November 2025Class A Common Stock · traded 12 November 2025 · filed 14 November 2025
- exercised options over 95,525 shares of Amneal PharmaceuticalsSEC Form 414 November 2025Class A Common Stock · traded 12 November 2025 · filed 14 November 2025
- ▼ sold on the open market 131,856 shares of Amneal PharmaceuticalsSEC Form 414 November 2025Class A Common Stock · traded 12 November 2025 · filed 14 November 2025
- ▼ sold on the open market 114,492 shares of Amneal PharmaceuticalsSEC Form 425 August 2025Class A Common Stock · traded 22 August 2025 · filed 25 August 2025
- ▼ sold on the open market 6,340 shares of Amneal PharmaceuticalsSEC Form 425 August 2025Class A Common Stock · traded 25 August 2025 · filed 25 August 2025
- ▼ sold on the open market 71,694 shares of Amneal PharmaceuticalsSEC Form 415 August 2025Class A Common Stock · traded 14 August 2025 · filed 15 August 2025
- ▼ sold on the open market 50,000 shares of Amneal PharmaceuticalsSEC Form 413 August 2025Class A Common Stock · traded 12 August 2025 · filed 13 August 2025
- ▼ sold on the open market 49,140 shares of Amneal PharmaceuticalsSEC Form 419 May 2025Class A Common Stock · traded 16 May 2025 · filed 19 May 2025
- exercised options over 36,232 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 45 March 2025Restricted Stock Units · traded 3 March 2025 · filed 5 March 2025
- exercised options over 45,872 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 45 March 2025Restricted Stock Units · traded 3 March 2025 · filed 5 March 2025
- exercised options over 144,928 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 45 March 2025Performance-Based Restricted Stock Units · traded 3 March 2025 · filed 5 March 2025
- was granted 188,356 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 45 March 2025Performance-Based Restricted Stock Units · traded 3 March 2025 · filed 5 March 2025
- was granted 94,178 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 45 March 2025Restricted Stock Units · traded 3 March 2025 · filed 5 March 2025
- exercised options over 35,879 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 45 March 2025Restricted Stock Units · traded 4 March 2025 · filed 5 March 2025
- exercised options over 36,232 shares of Amneal PharmaceuticalsSEC Form 45 March 2025Class A Common Stock · traded 3 March 2025 · filed 5 March 2025
- had shares withheld for tax on 18,533 shares of Amneal PharmaceuticalsSEC Form 45 March 2025Class A Common Stock · traded 3 March 2025 · filed 5 March 2025
- exercised options over 45,872 shares of Amneal PharmaceuticalsSEC Form 45 March 2025Class A Common Stock · traded 3 March 2025 · filed 5 March 2025
- had shares withheld for tax on 23,464 shares of Amneal PharmaceuticalsSEC Form 45 March 2025Class A Common Stock · traded 3 March 2025 · filed 5 March 2025
- exercised options over 144,928 shares of Amneal PharmaceuticalsSEC Form 45 March 2025Class A Common Stock · traded 3 March 2025 · filed 5 March 2025
- had shares withheld for tax on 74,131 shares of Amneal PharmaceuticalsSEC Form 45 March 2025Class A Common Stock · traded 3 March 2025 · filed 5 March 2025
- exercised options over 35,879 shares of Amneal PharmaceuticalsSEC Form 45 March 2025Class A Common Stock · traded 4 March 2025 · filed 5 March 2025
- had shares withheld for tax on 18,353 shares of Amneal PharmaceuticalsSEC Form 45 March 2025Class A Common Stock · traded 4 March 2025 · filed 5 March 2025
- exercised options over 28,958 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 44 March 2025Restricted Stock Units · traded 1 March 2025 · filed 4 March 2025
- exercised options over 28,958 shares of Amneal PharmaceuticalsSEC Form 44 March 2025Class A Common Stock · traded 1 March 2025 · filed 4 March 2025
- had shares withheld for tax on 10,985 shares of Amneal PharmaceuticalsSEC Form 44 March 2025Class A Common Stock · traded 1 March 2025 · filed 4 March 2025
- ▼ sold on the open market 100,000 shares of Amneal PharmaceuticalsSEC Form 416 August 2024Class A Common Stock · traded 14 August 2024 · filed 16 August 2024
- exercised options over 28,957 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 45 March 2024Restricted Stock Units · traded 1 March 2024 · filed 5 March 2024
- exercised options over 36,232 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 45 March 2024Restricted Stock Units · traded 3 March 2024 · filed 5 March 2024
- exercised options over 45,871 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 45 March 2024Restricted Stock Units · traded 3 March 2024 · filed 5 March 2024
- was granted 143,519 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 45 March 2024Restricted Stock Units · traded 4 March 2024 · filed 5 March 2024
- was granted 287,038 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 45 March 2024Performance-Based Restricted Stock Units · traded 4 March 2024 · filed 5 March 2024
- exercised options over 28,957 shares of Amneal PharmaceuticalsSEC Form 45 March 2024Class A Common Stock · traded 1 March 2024 · filed 5 March 2024
- had shares withheld for tax on 15,181 shares of Amneal PharmaceuticalsSEC Form 45 March 2024Class A Common Stock · traded 1 March 2024 · filed 5 March 2024
- exercised options over 36,232 shares of Amneal PharmaceuticalsSEC Form 45 March 2024Class A Common Stock · traded 3 March 2024 · filed 5 March 2024
- had shares withheld for tax on 18,153 shares of Amneal PharmaceuticalsSEC Form 45 March 2024Class A Common Stock · traded 3 March 2024 · filed 5 March 2024
- exercised options over 45,871 shares of Amneal PharmaceuticalsSEC Form 45 March 2024Class A Common Stock · traded 3 March 2024 · filed 5 March 2024
- had shares withheld for tax on 22,982 shares of Amneal PharmaceuticalsSEC Form 45 March 2024Class A Common Stock · traded 3 March 2024 · filed 5 March 2024
- exercised options over 35,620 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 429 February 2024Restricted Stock Units · traded 27 February 2024 · filed 29 February 2024
- exercised options over 35,620 shares of Amneal PharmaceuticalsSEC Form 429 February 2024Class A Common Stock · traded 27 February 2024 · filed 29 February 2024
- had shares withheld for tax on 18,670 shares of Amneal PharmaceuticalsSEC Form 429 February 2024Class A Common Stock · traded 27 February 2024 · filed 29 February 2024
- exercised options over 36,232 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 47 March 2023Restricted Stock Units · traded 3 March 2023 · filed 7 March 2023
- was granted 183,486 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 47 March 2023Restricted Stock Units · traded 3 March 2023 · filed 7 March 2023
- was granted 366,972 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 47 March 2023Performance-Based Restricted Stock Units · traded 3 March 2023 · filed 7 March 2023
- exercised options over 36,232 shares of Amneal PharmaceuticalsSEC Form 47 March 2023Class A Common Stock · traded 3 March 2023 · filed 7 March 2023
- had shares withheld for tax on 18,064 shares of Amneal PharmaceuticalsSEC Form 47 March 2023Class A Common Stock · traded 3 March 2023 · filed 7 March 2023
- exercised options over 11,729 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 43 March 2023Restricted Stock Units · traded 1 March 2023 · filed 3 March 2023
- exercised options over 28,958 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 43 March 2023Restricted Stock Units · traded 1 March 2023 · filed 3 March 2023
- exercised options over 11,729 shares of Amneal PharmaceuticalsSEC Form 43 March 2023Class A Common Stock · traded 1 March 2023 · filed 3 March 2023
- had shares withheld for tax on 6,504 shares of Amneal PharmaceuticalsSEC Form 43 March 2023Class A Common Stock · traded 1 March 2023 · filed 3 March 2023
- exercised options over 28,958 shares of Amneal PharmaceuticalsSEC Form 43 March 2023Class A Common Stock · traded 1 March 2023 · filed 3 March 2023
- had shares withheld for tax on 15,555 shares of Amneal PharmaceuticalsSEC Form 43 March 2023Class A Common Stock · traded 1 March 2023 · filed 3 March 2023
- exercised options over 35,620 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 41 March 2023Restricted Stock Units · traded 27 February 2023 · filed 1 March 2023
- exercised options over 35,620 shares of Amneal PharmaceuticalsSEC Form 41 March 2023Class A Common Stock · traded 27 February 2023 · filed 1 March 2023
- had shares withheld for tax on 19,752 shares of Amneal PharmaceuticalsSEC Form 41 March 2023Class A Common Stock · traded 27 February 2023 · filed 1 March 2023
- exercised options over 4,442 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 410 May 2022Restricted Stock Units · traded 7 May 2022 · filed 10 May 2022
- exercised options over 4,442 shares of Amneal PharmaceuticalsSEC Form 410 May 2022Class A Common Stock · traded 7 May 2022 · filed 10 May 2022
- had shares withheld for tax on 2,228 shares of Amneal PharmaceuticalsSEC Form 410 May 2022Class A Common Stock · traded 7 May 2022 · filed 10 May 2022
- exercised options over 11,728 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 43 March 2022Restricted Stock Units · traded 1 March 2022 · filed 3 March 2022
- exercised options over 28,957 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 43 March 2022Restricted Stock Units · traded 1 March 2022 · filed 3 March 2022
- was granted 144,928 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 43 March 2022Restricted Stock Units · traded 3 March 2022 · filed 3 March 2022
- was granted 289,856 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 43 March 2022Performance-Based Restricted Stock Units · traded 3 March 2022 · filed 3 March 2022
- exercised options over 11,728 shares of Amneal PharmaceuticalsSEC Form 43 March 2022Class A Common Stock · traded 1 March 2022 · filed 3 March 2022
- had shares withheld for tax on 3,607 shares of Amneal PharmaceuticalsSEC Form 43 March 2022Class A Common Stock · traded 1 March 2022 · filed 3 March 2022
- exercised options over 28,957 shares of Amneal PharmaceuticalsSEC Form 43 March 2022Class A Common Stock · traded 1 March 2022 · filed 3 March 2022
- had shares withheld for tax on 8,905 shares of Amneal PharmaceuticalsSEC Form 43 March 2022Class A Common Stock · traded 1 March 2022 · filed 3 March 2022
- exercised options over 35,620 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 41 March 2022Restricted Stock Units · traded 27 February 2022 · filed 1 March 2022
- exercised options over 35,620 shares of Amneal PharmaceuticalsSEC Form 41 March 2022Class A Common Stock · traded 27 February 2022 · filed 1 March 2022
- had shares withheld for tax on 11,695 shares of Amneal PharmaceuticalsSEC Form 41 March 2022Class A Common Stock · traded 27 February 2022 · filed 1 March 2022
- ▼ sold on the open market 2,000 shares of Amneal PharmaceuticalsSEC Form 417 December 2021Class A Common Stock · traded 15 December 2021 · filed 17 December 2021
- exercised options over 4,441 shares of Amneal PharmaceuticalsSEC Form 411 May 2021Class A Common Stock · traded 7 May 2021 · filed 11 May 2021
- had shares withheld for tax on 1,366 shares of Amneal PharmaceuticalsSEC Form 411 May 2021Class A Common Stock · traded 7 May 2021 · filed 11 May 2021
- exercised options over 4,441 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 411 May 2021Restricted Stock Units · traded 7 May 2021 · filed 11 May 2021
- exercised options over 36,330 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 417 March 2021Stock Option (Right to Buy) · traded 15 March 2021 · filed 17 March 2021
- exercised options over 36,330 shares of Amneal PharmaceuticalsSEC Form 417 March 2021Class A Common Stock · traded 15 March 2021 · filed 17 March 2021
- ▼ sold on the open market 36,330 shares of Amneal PharmaceuticalsSEC Form 417 March 2021Class A Common Stock · traded 15 March 2021 · filed 17 March 2021
- was granted 115,830 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 43 March 2021Restricted Stock Units · traded 1 March 2021 · filed 3 March 2021
- was granted 231,660 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 43 March 2021Performance-Based Restricted Stock Units · traded 1 March 2021 · filed 3 March 2021
- exercised options over 35,620 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 42 March 2021Restricted Stock Units · traded 27 February 2021 · filed 2 March 2021
- exercised options over 11,729 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 42 March 2021Restricted Stock Units · traded 1 March 2021 · filed 2 March 2021
- exercised options over 35,620 shares of Amneal PharmaceuticalsSEC Form 42 March 2021Class A Common Stock · traded 27 February 2021 · filed 2 March 2021
- had shares withheld for tax on 11,548 shares of Amneal PharmaceuticalsSEC Form 42 March 2021Class A Common Stock · traded 27 February 2021 · filed 2 March 2021
- exercised options over 11,729 shares of Amneal PharmaceuticalsSEC Form 42 March 2021Class A Common Stock · traded 1 March 2021 · filed 2 March 2021
- had shares withheld for tax on 3,607 shares of Amneal PharmaceuticalsSEC Form 42 March 2021Class A Common Stock · traded 1 March 2021 · filed 2 March 2021
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.